» Articles » PMID: 37624172

Heated Tobacco Products: Insights into Composition and Toxicity

Overview
Journal Toxics
Date 2023 Aug 25
PMID 37624172
Authors
Affiliations
Soon will be listed here.
Abstract

Heated tobacco products (HTPs) are novel products that allow users to inhale nicotine by heating (350 °C) reconstituted tobacco rather than combustion (900 °C) as in conventional cigarettes. HTP sticks containing reconstituted tobacco come in various flavours such as menthol, citrus, etc., like electronic cigarette liquids. Thus, the composition of HTP aerosol will also vary according to the flavouring agents added. Overall, the content of toxic chemicals in HTP aerosol appears to be lower than in cigarette smoke. However, the concentrations of more than twenty harmful and potentially harmful constituents have been reported to be higher in HTP aerosol than in cigarette smoke. Further, several toxic compounds not detected in cigarette smoke are also reported in HTP aerosol. Thus, the risks of HTP use remain unknown. Most of the available data on the composition and health effects of mainstream HTP aerosol exposure are generated by the tobacco industry. Few independent studies have reported short-term pathophysiological effects of HTP use. Currently available HTP toxicity data are mainly on the pulmonary and cardiovascular systems. Moreover, there are no long-term toxicity data and, therefore, the claims of the tobacco industry regarding HTPs as a safer alternative to traditional combustible cigarettes are unsubstantiated. Furthermore, HTP aerosol contains the highly addictive substance nicotine, which is harmful to the adolescent brain, developing foetuses, pregnant women, and also adults. Hence, comprehensive studies addressing the safety profiling related to long-term HTP use are warranted. With this background, the following review summarizes the current state of knowledge on HTP toxicity on four broad lines: composition of mainstream HTP aerosol compared to traditional combustible cigarette smoke, biomarkers of HTP exposure, health effects of HTP exposure, and the harm reduction aspect.

Citing Articles

Changes in Concentration of Selected Biomarkers of Exposure in Users of Classic Cigarettes, E-Cigarettes, and Heated Tobacco Products-A Narrative Review.

Sniadach J, Kicman A, Michalska-Falkowska A, Jonczyk K, Waszkiewicz N Int J Mol Sci. 2025; 26(5).

PMID: 40076424 PMC: 11898610. DOI: 10.3390/ijms26051796.


Evaluation and Comparison of Capillary Morphology Among Combusted Tobacco, Heated Tobacco and E-Cigarette Users.

Nigliaccio S, Fontana D, Cacioppo A, Curcio L, Cumbo E, Scardina G Biology (Basel). 2025; 14(2).

PMID: 40001931 PMC: 11851900. DOI: 10.3390/biology14020163.


Relationship Between Heated Tobacco Products and Placental Abruption: A Prospective Cohort Study Using Online Questionnaire.

Ooba H, Maki J, Tabuchi T, Masuyama H J Epidemiol Glob Health. 2025; 15(1):30.

PMID: 39976798 PMC: 11842668. DOI: 10.1007/s44197-025-00373-2.


Heat-not-burn technology affects plasma testosterone levels and markers of inflammation, oxidative stress in the testes of rats.

Granata S, Morosini C, Valerii M, Fagiolino I, Sangiorgi S, Ghini S Front Toxicol. 2025; 6:1515850.

PMID: 39902465 PMC: 11788375. DOI: 10.3389/ftox.2024.1515850.


Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis.

Valeriani F, Protano C, Pozzoli A, Vitale K, Liguori F, Liguori G Vaccines (Basel). 2024; 12(11).

PMID: 39591163 PMC: 11599009. DOI: 10.3390/vaccines12111260.


References
1.
Leigh N, Palumbo M, Marino A, OConnor R, Goniewicz M . Tobacco-specific nitrosamines (TSNA) in heated tobacco product IQOS. Tob Control. 2018; 27(Suppl 1):s37-s38. PMC: 6252482. DOI: 10.1136/tobaccocontrol-2018-054318. View

2.
Basaran R, Guven N, Can Eke B . An Overview of iQOS as a New Heat-Not-Burn Tobacco Product and Its Potential Effects on Human Health and the Environment. Turk J Pharm Sci. 2020; 16(3):371-374. PMC: 7227951. DOI: 10.4274/tjps.galenos.2018.79095. View

3.
Bals R, Boyd J, Esposito S, Foronjy R, Hiemstra P, Jimenez-Ruiz C . Electronic cigarettes: a task force report from the European Respiratory Society. Eur Respir J. 2018; 53(2). DOI: 10.1183/13993003.01151-2018. View

4.
Czoli C, White C, Reid J, OConnor R, Hammond D . Awareness and interest in IQOS heated tobacco products among youth in Canada, England and the USA. Tob Control. 2019; 29(1):89-95. PMC: 7958490. DOI: 10.1136/tobaccocontrol-2018-054654. View

5.
Pataka A, Kotoulas S, Chatzopoulos E, Grigoriou I, Sapalidis K, Kosmidis C . Acute Effects of a Heat-Not-Burn Tobacco Product on Pulmonary Function. Medicina (Kaunas). 2020; 56(6). PMC: 7353844. DOI: 10.3390/medicina56060292. View